When stratifying the new ILD developers according to CXCL10 median levels at baseline (below and above median CXCL10 levels), we found that CXCL10 levels >78.5 pg/ml were associated with increased hazard of developing new onset of ILD [HR = 2.74, 95% CI (0.78 to 8.42)]. Here, CXCL10 is linked to interstitial lung disease.